Table of Contents

1 Molecular Diagnostic Kits Market Overview

• 1.1 Product Overview and Scope of Molecular Diagnostic Kits
• 1.2 Molecular Diagnostic Kits Segment by Type
  • 1.2.1 Global Molecular Diagnostic Kits Sales Growth Rate Comparison by Type (2022-2028)
  • 1.2.2 PCR
  • 1.2.3 Gene Chip
  • 1.2.4 Fluorescence in Situ Hybridization
  • 1.2.5 DNA Sequencing
• 1.3 Molecular Diagnostic Kits Segment by Application
  • 1.3.1 Global Molecular Diagnostic Kits Sales Comparison by Application: (2022-2028)
  • 1.3.2 Infectious Disease Diagnosis
  • 1.3.3 Genetic Diagnosis
  • 1.3.4 Blood Screening
  • 1.3.5 Other
• 1.4 Global Molecular Diagnostic Kits Market Size Estimates and Forecasts
  • 1.4.1 Global Molecular Diagnostic Kits Revenue 2017-2028
  • 1.4.2 Global Molecular Diagnostic Kits Sales 2017-2028
  • 1.4.3 Molecular Diagnostic Kits Market Size by Region: 2017 Versus 2021 Versus 2028

2 Molecular Diagnostic Kits Market Competition by Manufacturers

• 2.1 Global Molecular Diagnostic Kits Sales Market Share by Manufacturers (2017-2022)
• 2.2 Global Molecular Diagnostic Kits Revenue Market Share by Manufacturers (2017-2022)
• 2.3 Global Molecular Diagnostic Kits Average Price by Manufacturers (2017-2022)
• 2.4 Manufacturers Molecular Diagnostic Kits Manufacturing Sites, Area Served, Product Type
• 2.5 Molecular Diagnostic Kits Market Competitive Situation and Trends
  • 2.5.1 Molecular Diagnostic Kits Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Molecular Diagnostic Kits Players Market Share by Revenue
  • 2.5.3 Global Molecular Diagnostic Kits Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Molecular Diagnostic Kits Retrospective Market Scenario by Region

• 3.1 Global Molecular Diagnostic Kits Retrospective Market Scenario in Sales by Region: 2017-2022
• 3.2 Global Molecular Diagnostic Kits Retrospective Market Scenario in Revenue by Region: 2017-2022
• 3.3 North America Molecular Diagnostic Kits Market Facts & Figures by Country
  • 3.3.1 North America Molecular Diagnostic Kits Sales by Country
  • 3.3.2 North America Molecular Diagnostic Kits Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Molecular Diagnostic Kits Market Facts & Figures by Country
  • 3.4.1 Europe Molecular Diagnostic Kits Sales by Country
  • 3.4.2 Europe Molecular Diagnostic Kits Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Molecular Diagnostic Kits Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Molecular Diagnostic Kits Sales by Region
  • 3.5.2 Asia Pacific Molecular Diagnostic Kits Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Molecular Diagnostic Kits Market Facts & Figures by Country
  • 3.6.1 Latin America Molecular Diagnostic Kits Sales by Country
  • 3.6.2 Latin America Molecular Diagnostic Kits Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Molecular Diagnostic Kits Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Molecular Diagnostic Kits Sales by Country
  • 3.7.2 Middle East and Africa Molecular Diagnostic Kits Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Molecular Diagnostic Kits Historic Market Analysis by Type

• 4.1 Global Molecular Diagnostic Kits Sales Market Share by Type (2017-2022)
• 4.2 Global Molecular Diagnostic Kits Revenue Market Share by Type (2017-2022)
• 4.3 Global Molecular Diagnostic Kits Price by Type (2017-2022)

5 Global Molecular Diagnostic Kits Historic Market Analysis by Application

• 5.1 Global Molecular Diagnostic Kits Sales Market Share by Application (2017-2022)
• 5.2 Global Molecular Diagnostic Kits Revenue Market Share by Application (2017-2022)
• 5.3 Global Molecular Diagnostic Kits Price by Application (2017-2022)

6 Key Companies Profiled

• 6.1 Roche
  • 6.1.1 Roche Corporation Information
  • 6.1.2 Roche Description and Business Overview
  • 6.1.3 Roche Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.1.4 Roche Molecular Diagnostic Kits Product Portfolio
  • 6.1.5 Roche Recent Developments/Updates
• 6.2 Danaher
  • 6.2.1 Danaher Corporation Information
  • 6.2.2 Danaher Description and Business Overview
  • 6.2.3 Danaher Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.2.4 Danaher Molecular Diagnostic Kits Product Portfolio
  • 6.2.5 Danaher Recent Developments/Updates
• 6.3 Hologic
  • 6.3.1 Hologic Corporation Information
  • 6.3.2 Hologic Description and Business Overview
  • 6.3.3 Hologic Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.3.4 Hologic Molecular Diagnostic Kits Product Portfolio
  • 6.3.5 Hologic Recent Developments/Updates
• 6.4 Grifols
  • 6.4.1 Grifols Corporation Information
  • 6.4.2 Grifols Description and Business Overview
  • 6.4.3 Grifols Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Grifols Molecular Diagnostic Kits Product Portfolio
  • 6.4.5 Grifols Recent Developments/Updates
• 6.5 BioMérieux
  • 6.5.1 BioMérieux Corporation Information
  • 6.5.2 BioMérieux Description and Business Overview
  • 6.5.3 BioMérieux Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.5.4 BioMérieux Molecular Diagnostic Kits Product Portfolio
  • 6.5.5 BioMérieux Recent Developments/Updates
• 6.6 Qiagen
  • 6.6.1 Qiagen Corporation Information
  • 6.6.2 Qiagen Description and Business Overview
  • 6.6.3 Qiagen Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.6.4 Qiagen Molecular Diagnostic Kits Product Portfolio
  • 6.6.5 Qiagen Recent Developments/Updates
• 6.7 Abbott
  • 6.6.1 Abbott Corporation Information
  • 6.6.2 Abbott Description and Business Overview
  • 6.6.3 Abbott Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.4.4 Abbott Molecular Diagnostic Kits Product Portfolio
  • 6.7.5 Abbott Recent Developments/Updates
• 6.8 Thermo Fisher
  • 6.8.1 Thermo Fisher Corporation Information
  • 6.8.2 Thermo Fisher Description and Business Overview
  • 6.8.3 Thermo Fisher Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.8.4 Thermo Fisher Molecular Diagnostic Kits Product Portfolio
  • 6.8.5 Thermo Fisher Recent Developments/Updates
• 6.9 Bio-Rad
  • 6.9.1 Bio-Rad Corporation Information
  • 6.9.2 Bio-Rad Description and Business Overview
  • 6.9.3 Bio-Rad Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.9.4 Bio-Rad Molecular Diagnostic Kits Product Portfolio
  • 6.9.5 Bio-Rad Recent Developments/Updates
• 6.10 Illumina
  • 6.10.1 Illumina Corporation Information
  • 6.10.2 Illumina Description and Business Overview
  • 6.10.3 Illumina Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.10.4 Illumina Molecular Diagnostic Kits Product Portfolio
  • 6.10.5 Illumina Recent Developments/Updates
• 6.11 Siemens
  • 6.11.1 Siemens Corporation Information
  • 6.11.2 Siemens Molecular Diagnostic Kits Description and Business Overview
  • 6.11.3 Siemens Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.11.4 Siemens Molecular Diagnostic Kits Product Portfolio
  • 6.11.5 Siemens Recent Developments/Updates
• 6.12 Agilent
  • 6.12.1 Agilent Corporation Information
  • 6.12.2 Agilent Molecular Diagnostic Kits Description and Business Overview
  • 6.12.3 Agilent Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.12.4 Agilent Molecular Diagnostic Kits Product Portfolio
  • 6.12.5 Agilent Recent Developments/Updates
• 6.13 Daangene
  • 6.13.1 Daangene Corporation Information
  • 6.13.2 Daangene Molecular Diagnostic Kits Description and Business Overview
  • 6.13.3 Daangene Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.13.4 Daangene Molecular Diagnostic Kits Product Portfolio
  • 6.13.5 Daangene Recent Developments/Updates
• 6.14 Diasorin
  • 6.14.1 Diasorin Corporation Information
  • 6.14.2 Diasorin Molecular Diagnostic Kits Description and Business Overview
  • 6.14.3 Diasorin Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.14.4 Diasorin Molecular Diagnostic Kits Product Portfolio
  • 6.14.5 Diasorin Recent Developments/Updates
• 6.15 Merck
  • 6.15.1 Merck Corporation Information
  • 6.15.2 Merck Molecular Diagnostic Kits Description and Business Overview
  • 6.15.3 Merck Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.15.4 Merck Molecular Diagnostic Kits Product Portfolio
  • 6.15.5 Merck Recent Developments/Updates
• 6.16 KHB
  • 6.16.1 KHB Corporation Information
  • 6.16.2 KHB Molecular Diagnostic Kits Description and Business Overview
  • 6.16.3 KHB Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.16.4 KHB Molecular Diagnostic Kits Product Portfolio
  • 6.16.5 KHB Recent Developments/Updates
• 6.17 liferiver
  • 6.17.1 liferiver Corporation Information
  • 6.17.2 liferiver Molecular Diagnostic Kits Description and Business Overview
  • 6.17.3 liferiver Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.17.4 liferiver Molecular Diagnostic Kits Product Portfolio
  • 6.17.5 liferiver Recent Developments/Updates
• 6.18 Leadman
  • 6.18.1 Leadman Corporation Information
  • 6.18.2 Leadman Molecular Diagnostic Kits Description and Business Overview
  • 6.18.3 Leadman Molecular Diagnostic Kits Sales, Revenue and Gross Margin (2017-2022)
  • 6.18.4 Leadman Molecular Diagnostic Kits Product Portfolio
  • 6.18.5 Leadman Recent Developments/Updates

7 Molecular Diagnostic Kits Manufacturing Cost Analysis

• 7.1 Molecular Diagnostic Kits Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Molecular Diagnostic Kits
• 7.4 Molecular Diagnostic Kits Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Molecular Diagnostic Kits Distributors List
• 8.3 Molecular Diagnostic Kits Customers

9 Molecular Diagnostic Kits Market Dynamics

• 9.1 Molecular Diagnostic Kits Industry Trends
• 9.2 Molecular Diagnostic Kits Market Drivers
• 9.3 Molecular Diagnostic Kits Market Challenges
• 9.4 Molecular Diagnostic Kits Market Restraints

10 Global Market Forecast

• 10.1 Molecular Diagnostic Kits Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Molecular Diagnostic Kits by Type (2023-2028)
  • 10.1.2 Global Forecasted Revenue of Molecular Diagnostic Kits by Type (2023-2028)
• 10.2 Molecular Diagnostic Kits Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Molecular Diagnostic Kits by Application (2023-2028)
  • 10.2.2 Global Forecasted Revenue of Molecular Diagnostic Kits by Application (2023-2028)
• 10.3 Molecular Diagnostic Kits Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Molecular Diagnostic Kits by Region (2023-2028)
  • 10.3.2 Global Forecasted Revenue of Molecular Diagnostic Kits by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

Summary:

Industry Insights
Due to the COVID-19 pandemic, the global Molecular Diagnostic Kits market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Molecular Diagnostic Kits market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Molecular Diagnostic Kits landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
PCR accounting for % of the Molecular Diagnostic Kits global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Infectious Disease Diagnosis segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Molecular Diagnostic Kits include Roche, Danaher, Hologic, Grifols, BioMérieux, Qiagen, Abbott, Thermo Fisher and Bio-Rad, etc. In terms of revenue, the global 3 largest players have a % market share of Molecular Diagnostic Kits in 2021.
This report focuses on Molecular Diagnostic Kits volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Molecular Diagnostic Kits market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Post-covid-19 Outlook
The readers in the section will understand how the Molecular Diagnostic Kits market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Segmental Outlook
Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
Segment by Type
PCR
Gene Chip
Fluorescence in Situ Hybridization
DNA Sequencing
Segment by Application
Infectious Disease Diagnosis
Genetic Diagnosis
Blood Screening
Other
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Scenario
In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Roche
Danaher
Hologic
Grifols
BioMérieux
Qiagen
Abbott
Thermo Fisher
Bio-Rad
Illumina
Siemens
Agilent
Daangene
Diasorin
Merck
KHB
liferiver
Leadman
Frequently Asked Questions
Which product segment grabbed the largest share in the Molecular Diagnostic Kits market?
How is the competitive scenario of the Molecular Diagnostic Kits market?
Which are the key factors aiding the Molecular Diagnostic Kits market growth?
Which are the prominent players in the Molecular Diagnostic Kits market?
Which region holds the maximum share in the Molecular Diagnostic Kits market?
What will be the CAGR of the Molecular Diagnostic Kits market during the forecast period?
Which application segment emerged as the leading segment in the Molecular Diagnostic Kits market?
What key trends are likely to emerge in the Molecular Diagnostic Kits market in the coming years?
What will be the Molecular Diagnostic Kits market size by 2028?
Which company held the largest share in the Molecular Diagnostic Kits market?